BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 18753342)

  • 1. Rapid method for sensitive screening of oligosaccharide epitopes in the lipooligosaccharide from Campylobacter jejuni strains isolated from Guillain-Barré syndrome and Miller Fisher syndrome patients.
    Dzieciatkowska M; Liu X; Heikema AP; Houliston RS; van Belkum A; Schweda EK; Gilbert M; Richards JC; Li J
    J Clin Microbiol; 2008 Oct; 46(10):3429-36. PubMed ID: 18753342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural characterization of Campylobacter jejuni lipooligosaccharide outer cores associated with Guillain-Barre and Miller Fisher syndromes.
    Godschalk PC; Kuijf ML; Li J; St Michael F; Ang CW; Jacobs BC; Karwaski MF; Brochu D; Moterassed A; Endtz HP; van Belkum A; Gilbert M
    Infect Immun; 2007 Mar; 75(3):1245-54. PubMed ID: 17261613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guillain-Barré syndrome- and Miller Fisher syndrome-associated Campylobacter jejuni lipopolysaccharides induce anti-GM1 and anti-GQ1b Antibodies in rabbits.
    Ang CW; De Klerk MA; Endtz HP; Jacobs BC; Laman JD; van der Meché FG; van Doorn PA
    Infect Immun; 2001 Apr; 69(4):2462-9. PubMed ID: 11254608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognition characteristics of monoclonal antibodies that are cross-reactive with gangliosides and lipooligosaccharide from Campylobacter jejuni strains associated with Guillain-Barré and Fisher syndromes.
    Houliston RS; Yuki N; Hirama T; Khieu NH; Brisson JR; Gilbert M; Jarrell HC
    Biochemistry; 2007 Jan; 46(1):36-44. PubMed ID: 17198373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients.
    Ang CW; Laman JD; Willison HJ; Wagner ER; Endtz HP; De Klerk MA; Tio-Gillen AP; Van den Braak N; Jacobs BC; Van Doorn PA
    Infect Immun; 2002 Mar; 70(3):1202-8. PubMed ID: 11854201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative genomic analysis of Campylobacter jejuni associated with Guillain-Barré and Miller Fisher syndromes: neuropathogenic and enteritis-associated isolates can share high levels of genomic similarity.
    Taboada EN; van Belkum A; Yuki N; Acedillo RR; Godschalk PC; Koga M; Endtz HP; Gilbert M; Nash JH
    BMC Genomics; 2007 Oct; 8():359. PubMed ID: 17919333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-infection with two different Campylobacter jejuni strains in a patient with the Guillain-Barré syndrome.
    Godschalk PC; Gilbert M; Jacobs BC; Kramers T; Tio-Gillen AP; Ang CW; Van den Braak N; Li J; Verbrugh HA; Van Belkum A; Endtz HP
    Microbes Infect; 2006 Jan; 8(1):248-53. PubMed ID: 16213180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophoresis-assisted open-tubular liquid chromatography/mass spectrometry for the analysis of lipooligosaccharide expressed by Campylobacter jejuni.
    Li J; Koga M; Brochu D; Yuki N; Chan K; Gilbert M
    Electrophoresis; 2005 Sep; 26(17):3360-8. PubMed ID: 16097024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mimicry between gangliosides and lipopolysaccharides of Campylobacter jejuni isolated from patients with Guillain-Barré syndrome and Miller Fisher syndrome.
    Yuki N
    J Infect Dis; 1997 Dec; 176 Suppl 2():S150-3. PubMed ID: 9396700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is Campylobacter lipopolysaccharide bearing a GD3 epitope essential for the pathogenesis of Guillain-Barré syndrome?
    Yuki N; Koga M; Hirata K
    Acta Neurol Scand; 2000 Aug; 102(2):132-4. PubMed ID: 10949532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mass spectrometric analysis of intact lipooligosaccharide: direct evidence for O-acetylated sialic acids and discovery of O-linked glycine expressed by Campylobacter jejuni.
    Dzieciatkowska M; Brochu D; van Belkum A; Heikema AP; Yuki N; Houliston RS; Richards JC; Gilbert M; Li J
    Biochemistry; 2007 Dec; 46(50):14704-14. PubMed ID: 18034462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipopolysaccharides in the development of the Guillain-Barré syndrome and Miller Fisher syndrome forms of acute inflammatory peripheral neuropathies.
    Prendergast MM; Moran AP
    J Endotoxin Res; 2000; 6(5):341-59. PubMed ID: 11521055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization of Campylobacter jejuni from patients with Guillain-Barré and Miller Fisher syndromes.
    Endtz HP; Ang CW; van Den Braak N; Duim B; Rigter A; Price LJ; Woodward DL; Rodgers FG; Johnson WM; Wagenaar JA; Jacobs BC; Verbrugh HA; van Belkum A
    J Clin Microbiol; 2000 Jun; 38(6):2297-301. PubMed ID: 10834992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Campylobacter jejuni enteritis and Guillain-Barré syndrome].
    Yuki N
    Rinsho Byori; 1999 Aug; 47(8):713-8. PubMed ID: 10511801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of Campylobacter jejuni isolated from patients with Guillain-Barré and Fisher syndromes in Japan.
    Takahashi M; Koga M; Yokoyama K; Yuki N
    J Clin Microbiol; 2005 Jan; 43(1):335-9. PubMed ID: 15634991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of DNA sequence variation in Campylobacter jejuni strains associated with the Guillain-Barré syndrome by high-throughput AFLP analysis.
    Godschalk PC; Bergman MP; Gorkink RF; Simons G; van den Braak N; Lastovica AJ; Endtz HP; Verbrugh HA; van Belkum A
    BMC Microbiol; 2006 Apr; 6():32. PubMed ID: 16594990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipo-oligosaccharides of Campylobacter jejuni serotype O:10. Structures of core oligosaccharide regions from a bacterial isolate from a patient with the Miller-Fisher syndrome and from the serotype reference strain.
    Shin JE; Ackloo S; Mainkar AS; Monteiro MA; Pang H; Penner JL; Aspinall GO
    Carbohydr Res; 1997 Dec; 305(2):223-32. PubMed ID: 9581276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Campylobacter jejuni from patients with Guillain-Barré syndrome preferentially expresses a GD(1a)-like epitope.
    Nachamkin I; Liu J; Li M; Ung H; Moran AP; Prendergast MM; Sheikh K
    Infect Immun; 2002 Sep; 70(9):5299-303. PubMed ID: 12183587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of Guillain-Barré and Miller Fisher syndromes subsequent to Campylobacter jejuni enteritis.
    Yuki N
    Jpn J Infect Dis; 1999 Jun; 52(3):99-105. PubMed ID: 10507987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of lipo-oligosaccharide loci of Campylobacter jejuni isolates associated with Guillain-Barré Syndrome from Hebei, China.
    Jiang H; Zhang MJ; Liu RC; Tian XY; Gu YX; Zhang JZ
    Int J Mol Sci; 2010 Mar; 11(3):1155-61. PubMed ID: 20480006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.